Skip to content

Decreased Gut Microbiome Tryptophan Metabolism and Serotonergic Signaling in Patients With Persistent Mental Health and Gastrointestinal Symptoms After COVID-19.

Randomized controlled trial · Clin Transl Gastroenterol · 2022. Source record refreshed; an explanation has not been reviewed.

Randomized controlled trialSource: PubMed · PMID 36049050

About this paper

This page identifies the publication and its source. A checked explanation of its findings is not yet available.

Reading this record

Checking bibliographic metadata does not verify a study’s conclusions or any advice previously linked to it.

CHECK THE ORIGINAL

Publication details

Decreased Gut Microbiome Tryptophan Metabolism and Serotonergic Signaling in Patients With Persistent Mental Health and Gastrointestinal Symptoms After COVID-19.

Blackett JW, Sun Y, Purpura L et al.
Clin Transl Gastroenterol · 2022

PubMed ID
36049050
Record checked

A checked publication record confirms source details. It does not verify a health claim or assess the quality of the study. Our approach.